What role does VKORC1 play in menopause?

VKORC1 (vitamin K epoxide reductase complex subunit 1) is a key enzyme in the vitamin K cycle. It recycles vitamin K to activate vitamin K-dependent proteins, including clotting factors, osteocalcin, and matrix Gla protein (MGP), which are important for bone mineralization and vascular health. During menopause, estrogen decline accelerates bone loss and increases cardiovascular risk. VKORC1 polymorphisms (e.g., -1639G>A) alter enzyme activity and vitamin K metabolism. Some studies have linked VKORC1 variants to bone mineral density and fracture risk in postmenopausal women, but findings are inconsistent. The evidence comes from candidate gene and GWAS studies, not from randomized controlled trials. VKORC1 does not directly cause or regulate menopause; rather, it may modulate the downstream effects of estrogen deficiency on bone and vascular tissues. Consumer DNA tests often include VKORC1 in menopause-related panels, but the predictive value is low and not clinically actionable. Caveat: effect sizes are small, and ancestry-specific differences exist. No current guidelines recommend VKORC1 testing for menopause management.